Literature DB >> 23500729

Synthesis and cellular compatibility of biomineralized Fe3O4 nanoparticles in tumor cells targeting peptides.

Yan Wei1, Guangfu Yin, Chuying Ma, Zhongbing Huang, Xianchun Chen, Xiaoming Liao, Yadong Yao, Hao Yin.   

Abstract

Fe3O4 nanoparticles (NPs) coated with WSG-peptide were prepared via a facile biomineralization technique at room temperature. The concentration of the peptides and the mixing time could substantially influence the morphology of as-prepared particles. The saturation magnetization of WSG-coated Fe3O4 particles were 35.92 emu/g, slightly higher than that of Fe3O4 without WSG peptides. Cell viability assay revealed that WSG-coated Fe3O4 particles had a good cellular compatibility. In addition, compared with Fe3O4 NPs, the mineralized Fe3O4 NPs coated with WSG peptides could more easily assemble into the cancer cell, indicating that the WSG-Fe3O4 NPs possess cancer targeting property. Thus, the WSG-coated Fe3O4 NPs could be used in cancer diagnosis and treatment fields.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500729     DOI: 10.1016/j.colsurfb.2013.01.058

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  3 in total

Review 1.  Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery.

Authors:  Samira Jafari; Solmaz Maleki Dizaj; Khosro Adibkia
Journal:  Bioimpacts       Date:  2015-04-22

2.  Low toxicity and long circulation time of polyampholyte-coated magnetic nanoparticles for blood pool contrast agents.

Authors:  Qi Wang; Ming Shen; Tao Zhao; Yuanyuan Xu; Jiang Lin; Yourong Duan; Hongchen Gu
Journal:  Sci Rep       Date:  2015-01-14       Impact factor: 4.379

3.  Structural and functional investigation of graphene oxide-Fe3O4 nanocomposites for the heterogeneous Fenton-like reaction.

Authors:  Nor Aida Zubir; Christelle Yacou; Julius Motuzas; Xiwang Zhang; João C Diniz da Costa
Journal:  Sci Rep       Date:  2014-04-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.